Neurofunctional and Neurochemical Markers of Treatment Response in Bipolar Disorder

NCT00608075 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

260

Enrollment

OTHER

Sponsor class

Conditions

Bipolar I Disorder

Interventions

DRUG: lithium
DRUG: Lithium

Sponsor

University of Cincinnati